Global Neuroscience Market Surges with Imaging Innovation and AI Integration
The global Neuroscience Market size was valued at USD 35.3 billion in 2023 and is projected to reach USD 50.2 billion by 2032, expanding at a CAGR of 4.00% from 2024 to 2032. This growth is driven by increasing demand for advanced neurodiagnostic and therapeutic technologies, strategic R&D investments, and an uptick in global neurological disease prevalence. From imaging technologies to brain mapping initiatives, the industry is undergoing a transformative shift that prioritizes precision, early detection, and minimally invasive treatment methods.
Instruments Segment Commands Market with 65.41% Share
By component, instruments dominated the neuroscience market in 2023, accounting for 65.41% of the total share. The surge in demand for advanced imaging and diagnostic tools for neurological conditions is a pivotal driver behind this growth. A notable innovation fueling this trend is the CT 3500 AI-powered computed tomography (CT) scanner introduced by Koninklijke Philips N.V. in May 2023. Designed for routine radiology and high-volume screening, this device offers enhanced imaging resolution and significantly improves diagnostic accuracy for clinicians.
Meanwhile, the consumables segment is expected to exhibit robust growth through 2032. Durable, easy-to-use neurology-specific consumables—developed by leading players like B. Braun SE and GE HealthCare—are increasingly adopted across hospitals and specialty clinics. Their scalability and consistent availability play a critical role in streamlining neurology procedures and improving patient outcomes.
Get a Free Sample Report of Neuroscience Market @ https://www.snsinsider.com/sample-request/3936
Brain Imaging Leads Technological Segmentation with 26.07% Market Share
In terms of technology, the brain imaging segment held the largest market share in 2023, representing 26.07%. The adoption of imaging modalities such as MRI, EEG, and CT scans continues to grow rapidly across diagnostic centers, hospitals, and ambulatory surgical centers (ASCs). According to NHS England, over 67,000 MRI brain scan referrals were made in March 2022, predominantly for cancer-related diagnostics. Such high dependency on imaging is projected to sustain the segment’s dominance.
Additionally, the neuro-microscopy segment is forecast to witness remarkable growth, spurred by cutting-edge innovations. In May 2023, MIT nanotechnologist Deblina Sarkar introduced ultra-small electronic machines capable of penetrating brain tissues to monitor or potentially reverse neurological damage. Market leaders like Danaher Corporation and Carl Zeiss AG are at the forefront of advancing this space with high-resolution neuro-microscopy systems, supporting real-time monitoring and surgical precision.
Regional Trends: North America Leads, Asia Pacific Rises Fast
Geographically, North America emerged as the dominant player in the neuroscience market in 2023, holding 32.52% of the total share. This leadership is attributed to the region’s advanced healthcare infrastructure, strategic investments, and a dense concentration of manufacturers focused on neurological diagnostics and therapeutics.
Noteworthy developments include Cerenovus’s expansion of its stroke care portfolio in March 2024 with innovative liquid embolic systems, enabling minimally invasive treatment of cerebrovascular diseases. The continuous R&D investment across the U.S. strengthens the region’s market hold and supports the launch of next-gen technologies.
The Asia Pacific region is anticipated to grow at the fastest rate over the forecast period. Rising healthcare expenditures, expanding infrastructure, and national-level neuroscience initiatives contribute to this trajectory. The U.S.-based BRAIN Initiative, launched by the NIH, gained momentum in 2023 through its BRAIN CONNECTS project, focused on decoding behavioral neural circuits. Comparable efforts, such as China’s Brain Project, aim to revolutionize brain disorder treatments, paving the way for substantial growth across Asia Pacific.
Leading Market Players Driving Innovation
Several key players are at the helm of neuroscience market innovation, consistently introducing new tools and pharmaceuticals to meet growing diagnostic and therapeutic needs:
Johnson & Johnson MedTech – EMBOGUARD Balloon Guide Catheter
Philips Healthcare – Philips Ingenia MRI Scanner
Medtronic – Mazor X Stealth Edition
GE Healthcare – Discovery MI PET/CT Scanner
Siemens Healthineers – SOMATOM X.cite CT Scanner
AbbVie – Vraylar (Cariprazine)
Boston Scientific – Neurovascular Stents
Cerenovus (J&J) – EMBOLIZER Balloon Catheter
NeuroPace – RNS System
Stryker Corporation – Penumbra Aspiration System
Elekta – Unity MR-Linac
Astellas Pharma – Xtandi (Enzalutamide)
NeuroSigma – Monarch eTNS System
Mindmaze – MindMotion GO
Cortech Solutions – NeuraLACE
Baxter International – Brain Anatomy Dissection Kit
Fresenius Medical Care – 4008S Hemodialysis Machine
Illumina – NovaSeq 6000 System
Biogen – Spinraza (Nusinersen)
Abbott Laboratories – Infinity Deep Brain Stimulation (DBS) System
Buy a Single-User PDF of Neuroscience Market Analysis & Outlook Report 2024-3936 @ https://www.snsinsider.com/checkout/3936
Recent Industry Developments
March 2024: Siemens Healthineers launched an advanced brain imaging solution integrating artificial intelligence, enabling faster, more accurate diagnostics for complex conditions such as multiple sclerosis.
January 2024: GE Healthcare unveiled next-generation MRI systems featuring enhanced resolution for improved detection of conditions like Alzheimer’s disease and brain tumors, strengthening their neuroimaging portfolio.
Outlook: Future Trajectory of the Neuroscience Market
As the prevalence of neurological diseases rises globally, the demand for high-performance, AI-enhanced diagnostic and therapeutic devices will surge. The future of the neuroscience market is intrinsically tied to precision medicine, real-time imaging, and multi-modal treatment strategies. Combined with global neuroscience initiatives and increasing investment in healthcare R&D, the market is on course to witness profound advancements that will redefine how neurological conditions are diagnosed and managed.
Read Our Other Report
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Jagney Dave – Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
